[Analysis of vaginal microecology in 23 181 cases of the gynecological female outpatients].
Zong XN, Feng YZ, Bai HH, Wang HSQ, Shang X, Fan LY, Li T, Zhang Z, Du MY, Liu ZH.
Zhonghua Fu Chan Ke Za Zhi. 2023 Mar 25;58(3):191-197. doi: 10.3760/cma.j.cn112141-20221212-00754.
PMID:36935196
Development and validation of a predictive model for the risk of developing trichomonas vaginitis in women.
Li Q, Li Y, Bai Y, Zhang H, Zhao W.
Sci Rep. 2022 Nov 23;12(1):20182. doi: 10.1038/s41598-022-24396-y.
PMID:36424393
Multipurpose prevention technologies: the future of HIV and STI protection.
Fernández-Romero JA, Deal C, Herold BC, Schiller J, Patton D, Zydowsky T, Romano J, Petro CD, Narasimhan M.
Trends Microbiol. 2015 Jul;23(7):429-436. doi: 10.1016/j.tim.2015.02.006. Epub 2015 Mar 7.
PMID:25759332
Sexually Transmitted Infections in Pregnancy: A Narrative Review of the Global Research Gaps, Challenges, and Opportunities.
Grant JS, Chico RM, Lee AC, Low N, Medina-Marino A, Molina RL, Morroni C, Ramogola-Masire D, Stafylis C, Tang W, Vallely AJ, Wynn A, Yeganeh N, Klausner JD.
Sex Transm Dis. 2020 Dec;47(12):779-789. doi: 10.1097/OLQ.0000000000001258.
PMID:32773611
[Therapy of combined vaginal infections with Trichomonas vaginalis and Blastomycetes. A controlled double-blind comparison of Metronidazole and Clotrimazole].
Schnell JD, Rüther C.
Geburtshilfe Frauenheilkd. 1974 Jul;34(7):551-7.
PMID:4849985
Optimization of Trichomonas vaginalis Diagnosis during Pregnancy at a University Hospital, Argentina.
Testardini P, Vaulet ML, Entrocassi AC, Menghi C, Eliseht MC, Gatta C, Losada M, Touzón MS, Corominas A, Vay C, Tatti S, Famiglietti A, Fermepin MR, Perazzi B.
Nitazoxanide and tizoxanide demonstrate high levels of in vitro activity against metronidazole-susceptible and metronidazole-resistant Trichomonas vaginalis clinical isolates.